Advertisement

Health


Starpharma shares plunge as UK sales paused over promotional claim concerns

Starpharma shares plunge as UK sales paused over promotional claim concerns

Pharmaceutical company Starpharma (ASX: SPL) and its retail partn...

Vitamins subscription healthtech Vitable nourished by $5.5m Series A raise

Vitamins subscription healthtech Vitable nourished by $5.5m Series A raise

A Sydney-based online platform for vitamin supplement subscriptio...

Are 3D-printed COVID tests the tip of the iceberg for Australian medical device manufacturing?

Are 3D-printed COVID tests the tip of the iceberg for Australian medical device manufacturing?

Australia's high labour costs have traditionally made it toug...

FDA rejuvenates Avita Medical burns treatment

FDA rejuvenates Avita Medical burns treatment

Avita Medical Inc. (ASX: AVH) has received a big shot in the arm ...

Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug

Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug

Investors in Melbourne-based digital cognitive assessment technol...

Advertisement
Advertisement
Advertisement
ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

ANTG enters partnership with hopes to export first medicinal cannabis flower to NZ

Earlier this year a Byron Bay-based company achieved a milestone ...

Could new findings put Mesoblast back in the COVID treatment race?

Could new findings put Mesoblast back in the COVID treatment race?

After four months in the doldrums due to its COVID-19 treatment i...

AnteoTech launches 15-minute COVID-19 test in Europe

AnteoTech launches 15-minute COVID-19 test in Europe

Brisbane-based biotech firm AnteoTech (ASX: ADO) has officially l...

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics (ASX: ECS) has submitted plans to the Office of Drug...

Creso Pharma appoints director of US business after New York legalises marijuana

Creso Pharma appoints director of US business after New York legalises marijuana

Australian medicinal cannabis company Creso Pharma (ASX: CPH) has...

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Stem cell therapeutics company Cynata's (ASX: CYP) pool of el...

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Pharmaceuticals manufacturer Starpharma (ASX: SPL) will commence ...

New US trial finds AstraZeneca vaccine 79 per cent effective

New US trial finds AstraZeneca vaccine 79 per cent effective

A Phase III trial of the AstraZeneca vaccine in the US has demons...

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Buy-now pay-later (BNPL) operator Openpay (ASX: OPY) has announce...

IDT looks to manufacture COVID-19 vaccines on-shore

IDT looks to manufacture COVID-19 vaccines on-shore

Victorian pharmaceuticals manufacturer IDT Australia (ASX: IDT) h...

Centuria to build Melbourne hospital for doctor-led Medicare JV

Centuria to build Melbourne hospital for doctor-led Medicare JV

A subsidiary of Centuria Capital Group (ASX: CNI) has entered a p...

People Infrastructure acquires SwingShift Nurses

People Infrastructure acquires SwingShift Nurses

Workforce management company People Infrastructure (ASX: PPE) con...

Elixinol to bag German CBD brand for $13.9m

Elixinol to bag German CBD brand for $13.9m

Australian cannabis company Elixinol's (ASX: EXL) plans to pu...

Advertisement

Partner Content

Netball Queensland and the Queensland Firebirds are excited to an...
If you've picked up eToro in the last 12 months, or you'r...
Any reputable financial advisor will tell you that a diverse port...
Australian privately held cannabis company PharmaCann Global has ...
In recent years there's been a major revolution unfolding in ...
With a proven track record in North America and Europe, electronic ...
If you've been online at all recently, you'd have felt th...
Australian businesses could be losing billions of dollars due to ...
With many innovative functions like copy trading, crypto investme...
Whilst some cannabis stocks can trade on hype and future earnings...
Advertisement